Scholar Rock Holding (SRRK) Retained Earnings (2017 - 2026)
Scholar Rock Holding's quarterly Retained Earnings came in at $690000.0 in Q1 2026, up 100.07% year-on-year from $344880.7 in Q1 2025, and up 100.05% quarter-over-quarter from -$1.3 billion in Q4 2025.
Scholar Rock Holding has reported Retained Earnings for 10 years, with the latest figure at $690000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 100.07% year-over-year to $690000.0; the trailing twelve-month figure through Mar 2026 stood at $690000.0 (up 100.07% YoY), and the FY2025 full-year result was -$1.3 billion, down 813008.75% from the prior year.
- Retained Earnings for Q1 2026 stood at $690000.0, up from -$1.3 billion in the prior quarter.
- The five-year high for Retained Earnings was $690000.0 in Q1 2026, with the low at -$1.3 billion in Q4 2025.
- Average Retained Earnings over 5 years is -$433.7 million, with a median of -$510.6 million recorded in 2022.
- Year-over-year, Retained Earnings sank 1994776.0% in 2025 and soared 100.07% in 2026.
- Tracing SRRK's Retained Earnings over 5 years: stood at -$510.6 million in 2022, then tumbled by 32.47% to -$676.4 million in 2023, then jumped by 100.02% to $160000.0 in 2024, then slumped by 813008.75% to -$1.3 billion in 2025, then surged by 100.05% to $690000.0 in 2026.
- The last three Retained Earnings figures came in at $690000.0 (Q1 2026), -$1.3 billion (Q4 2025), and $117000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | 690,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 690,000.00 |
| Dec 31, 2025 | -1.30 Bn |
| Sep 30, 2025 | 117,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Mar 31, 2025 | -997.44 Mn |
| Dec 31, 2024 | 160,000.00 |
| Sep 30, 2024 | -856.26 Mn |
| Jun 30, 2024 | -791.80 Mn |
| Mar 31, 2024 | -50,000.00 |
| Dec 31, 2023 | -676.42 Mn |
| Sep 30, 2023 | -630.30 Mn |
| Jun 30, 2023 | -587.94 Mn |
| Mar 31, 2023 | -550.01 Mn |
| Dec 31, 2022 | -510.63 Mn |
| Sep 30, 2022 | -471.38 Mn |
| Jun 30, 2022 | -79,000.00 |
| Mar 31, 2022 | -152,000.00 |
| Dec 31, 2021 | -35,000.00 |
| Sep 30, 2021 | -340.22 Mn |
| Jun 30, 2021 | 9,000.00 |
| Mar 31, 2021 | 23,000.00 |
| Dec 31, 2020 | -244.33 Mn |
| Sep 30, 2020 | -217.76 Mn |
| Jun 30, 2020 | 49,000.00 |
| Mar 31, 2020 | -174.92 Mn |
| Dec 31, 2019 | -157.85 Mn |
| Sep 30, 2019 | -146.28 Mn |
| Jun 30, 2019 | 58,000.00 |
| Mar 31, 2019 | -117.60 Mn |
| Dec 31, 2018 | -106.85 Mn |
| Sep 30, 2018 | -91.89 Mn |
| Jun 30, 2018 | -81.12 Mn |
| Dec 31, 2017 | -2,000.00 |